Moderna had hoped its shot would be at least 49% effective at preventing CMV infections, substantially reducing the risk of ...

Moderna is halting development of an mRNA vaccine for congenital cytomegalovirus after its candidate failed to protect women ...

Moderna has decided to halt the development of its mRNA-1647 vaccine for congenital cytomegalovirus (CMV) infections – once ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Roche <a href=" target="_blank">(ROG.S) is partnering with Moderna <a href=" target="_blank">(MRNA.O) to include a COVID-19 antibody test in the mRNA specialist's ongoing vaccine trials, the Swiss ...

Moderna is backing the American Lung Association’s (ALA’s) call for people with lung diseases to get vaccinated for the ...

Moderna revealed Wednesday that its flu vaccine using mRNA technology has offered promising results as the flu season begins to ramp up. Moderna announced that its seasonal flu vaccine “demonstrated ...

Moderna is eyeing testing two vaccine candidates, one for mpox and another for bird flu, in humans later this year, Bloomberg reported March 6. The drugmaker’s president, Stephen Hoge, MD, said ...

Moderna and Merck’s new mRNA vaccine reduces the chance of relapse or death of skin cancer by half when paired with Merck’s immunotherapy drug Keytruda, new data shows, marking a step forward in the ...

Moderna has been rebuked by regulators after offering children cash to test the Covid vaccine. The pharmaceutical company was ordered to pay £14,000 after it emerged that a representative had sent a ...

Moderna has become a well-known name thanks to its highly effective COVID-19 vaccine, based on mRNA technology. But even before the pandemic hit, the company was developing an mRNA-based vaccine ...

ZURICH (Reuters) - Roche is partnering with Moderna to include a COVID-19 antibody test in the mRNA specialist's ongoing vaccine trials, the Swiss drugmaker said on Wednesday, potentially ...